Top Artificial Intelligence-Based Healthcare Mobile Apps and Their Use Cases

Articles

Limited Therapies in the Rare Disease Pipeline:...

Rare diseases affect a small percent of the population. In the United States, a rare disease is a condition that affects fewer than 200,000 people in the US (Orphan Drug Act ). In the European Unio...

Feb 12, 2021

Deerfield Dana Farber Deal FDA Nod to BMS Breyanzi & TG Ukoniq
Deerfield/ Dana-Farber’s USD 130 Million Cancer Research Deal; FDA-Approval to BMS’ Breyanzi & TG Therapeutics’ Ukoniq; EU Marketing Rights for ViiV Healthcare’s Rukobia

Deerfield and Dana-Farber Establish Links in USD 130 Million Cancer Research Deal  Deerfield Management has entered into a research agreement with Dana-Farber Cancer Institute to fuel the development of therapeutics and diagnostics for cancer. The move came not long after healthcare investor giant Deerfield...

Find More
Cystic Fibrosis Market | Vertex Pharmaceuticals
Cystic Fibrosis Market: A Rapidly Expanding Playing Field for Mid-Cap Pharma

Cystic Fibrosis is a rare inherited disorder that causes loss of lung function and damages the digestive system. It has a higher prevalence in the Caucasian population. For years there was no treatment available targeting the underlying cause, however, this changed in 2012 with the launch of Vertex Pharma’s Kalydec...

Find More
Smoking Cessation Market | Quitting Tobacco | Nicotine-addiction |
The Mesh of the Generics and the Potential of Emerging Therapies in the Smoking Cessation Market

Smoking is the leading preventable cause of death in the world. However, prior to 1900, tobacco smoking was an uncommon sight. It was not until the 20th century that smoking cigarettes became a routine or more precisely a popular trend among youths and adults. What helped in booming its adoption were effective adve...

Find More

More Views & Analysis

Chronic Refractory Cough Market | Chronic refractory cough Treatment
Chronic Refractory Cough Market and the Monopoly of the Over-The-Counter Drugs

Cough! Cough! Every time something goes down the wrong pipe, we cough it out. Within seconds, it gets normal. We catch flu, or cold, cough accompanies for a week or two. However, what if cough decides to befriend the person for a time period more than usual, say, around eight weeks or more? It can be worrisome, and...

Find More

Hyperkalemia Treatment Market
Notorious Hyperkalemia: What are the causes, signs and new treatments?

Bananas! Mostly everyone loves bananas. Who wouldn’t? They taste good and they are a rich source of potassium. Besides lovely bananas, oranges, cantaloupe, honeydew, apricots, grapefruit, red meat are some other rich sources of potassium that people include in their diets. On average, a healthy human body needs 4,7...

Find More

Hemophagocytic Lymphohistiocytosis Treatment Market
A Bleak Pipeline and Lack of Approved Treatment Clouds the Hemophagocytic Lymphohistiocytosis Market Size Growth

Having a strong immune system, flourished with properly working immune cells is the ultimate key to surviving a healthy life. However, what if a person is in possession of overactive immune cells? It leads to improper functioning of the immune system, confusing internal organs as foreign invaders thus attacking the...

Find More

Thrombocytopenia drugs market | Drug-Induced Thrombocytopenia
Thrombocytopenia Drugs Market: What Newer Agents Are Expected To Enter The Market?

The launch of a novel drug in the market is not less than a celebration in the pharmaceutical and healthcare market; however, it also brings the real challenge of sustenance in the market. Similar is the picture of the Thrombocytopenia Drugs Market. Thrombocytopenia pipeline possesses potential drugs in mid-stage d...

Find More

Anxiety and COVID-19
We’re all in this together!

Overcoming Anxiety in the pandemic times!! The past year has been a tough journey for all of us. It has taught us many lessons that are going to stay with us for the whole of our lives. Thus, DelveInsight has decided to take you all on a ride full of experiences - some bitter and some sweet - yet with the power ...

Find More

Angelman Syndrome Market Landscape and Late-stage Clinical Failures
Angelman Syndrome Market: Insights Into The Recent Late-Stage Drug Failures And Novel Approaches To Treating This Rare Neurogenetic Disorder

Angelman syndrome (AS) is a complex genetic rare disorder that affects the nervous system. The first sign of a child suffering from Angelman syndrome is a delay in development, such as the inability to sit without support or making incoherent babbling sounds. The hallmarks of the syndrome constitute severe physical...

Find More

Gene Therapy has shown tremendous growth in the past few years. The use of AAV (adeno-associated vir.....

Find More

Cystic fibrosis (CF) is a hereditary condition leading to chronic lung infections and eventually dec.....

Find More

With its innovative approach, chimeric antigen receptor T cell therapy created a new dawn in the age.....

Find More

Advances in continuous glucose monitoring (CGM) has led to a paradigm shift in the management of typ.....

Find More

In the present scenario, the 3-D printing and bioprinting technology in the medical devices industry.....

Find More

Hemophilia, a genetic bleeding disorder characterized by a clotting factor protein deficiency. Intak.....

Find More